Administração de Surfactante

O surfactante exógeno reduz a mortalidade e a gravidade da Síndrome do Desconforto Respiratório.

Referências citadas

• Avoiding Endotracheal Ventilation to Prevent
  HENDRIK, S. Fischer; BÜHRER, Christoph. Avoiding Endotracheal Ventilation to Prevent. Pediatrics, 2013. Vol. 132 / Issue 5
• Surfactant administration in neonates: A review of delivery methods
  NOURAEYAN, N; LAMBRINAKOS, Raymond A; LEONE, M. et al. Surfactant administration in neonates: A review of delivery methods. Can J Respir Ther. 2014 Fall;50(3):91-5.
• Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants
  SUBRAMANIAM, Prema; HO, Jacqueline J; DAVIS, Peter G. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database of Systematic Reviews 2016, Issue 6.
• European Consensus Guidelines on the Management of Respiratory Distress Syndrome
  SWEET, DG; CARNIELLI, V; GREISEN, G. et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome – Neonatology 2017;111:107–125 2016 Update.

Artigos e documentos relacionados

• Severe airway obstruction during surfactant administration using a standardized protocol: a prospective, observational study
  TARAWNEH, A; KACZMAREK, J; BOTTINO, M N; SANT’ANNA, G M. Severe airway obstruction during surfactant administration using a standardized protocol: a prospective, observational study. Journal of Perinatology; New York32.4 (Apr 2012): 270-5.
• Assist control volume guarantee ventilation during surfactant administration
  WHEELER, K. Kevin; DAVIS, P G; KAMLIN, C O F; MORLEY, C J. Assist control volume guarantee ventilation during surfactant administration. Archives of Disease in Childhood – Fetal and Neonatal Edition 2009; 94 F313-F313 Published Online First: 21 Aug 2009.
• Administering surfactant without intubation – what does the laryngeal mask offer us?
  Administração de surfactante sem intubação – o que a máscara laríngea nos oferece?
  DARGAVILLE, Peter A. Administering surfactant without intubation – what does the laryngeal mask offer us? Administração de surfactante sem intubação – o que a máscara laríngea nos oferece? J Pediatr (Rio J). Editorial. 2017;93(4):313-316.
• Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis
  VENKATARAMAN, R; KAMALUDDEEN, M; HASAN, SU; ROBERTSON, HL; LODHA A. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis. Pediatr Pulmonol. 2017; 52:968–975.

• A Randomized Comparison of Surfactant Dosing via a Dual-lumen Endotracheal – Tube in Respiratory Distress Syndrome
  VALLS-I-SOLER, AL; FERNÁNDEZ-RUANOVA, B; ROMÁN, Etxebarría et al. A Randomized Comparison of Surfactant Dosing via a Dual-lumen Endotracheal – Tube in Respiratory Distress Syndrome. Pediatrics. April 1998, VOLUME 101 / ISSUE 4

Como citar

FUNDAÇÃO OSWALDO CRUZ. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente. Postagens: Administração de Surfactante. Rio de Janeiro, 2017. Disponível em: <https://portaldeboaspraticas.iff.fiocruz.br/atencao-recem-nascido/administracao-de-surfactante/>.